LENSAR Announces Presentations at American Academy of Ophthalmology Highlighting the Advantages of Streamline IV in Both Cataract and Astigmatism Corrective Surgery

ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical solutions for the treatment of cataracts, today announced that three posters and a paper have been accepted for virtual presentations at the Annual Meeting of the American Academy of Ophthalmology (AAO) being held November 13-15, 2020.

Paper Presentation

Paper title: Refractive Outcomes of a Light-Adjustable IOL in Cataract Patients With a History of RK

Presenter: James D Lehmann, MD, Focal Point Vision, San Antonio, TX

Date: The poster presentation will be available on the AAO meeting portal starting November 11, 2020

Poster Presentations

Presentation title: Outcome of Arcuate Keratotomy Using Iris Registration–Guided Femtosecond Laser for the Management of Astigmatism During Cataract Surgery

Presenter: Seong-Jun Lee, MD, PHD, Medical Director, Nuri Eye Clinic, Daejeon, Korea

Date: The poster presentation will be available on the AAO meeting portal starting November 11, 2020

Presentation title: Outcome of Toric IOLs Aligned With Iris Registration-Guided, FsL-Assisted Capsular Marks for the Management of Astigmatism During Cataract Surgery

Presenter: Seong-Jun Lee, MD, PHD, Medical Director, Nuri Eye Clinic, Daejeon, Korea

Date: The poster presentation will be available on the AAO meeting portal starting November 11, 2020

Presentation title: Femtosecond Laser-Assisted Capsulotomy With Capsular Marks for Guiding Toric IOL Alignment During Cataract Surgery

Presenter: Vasilios F Diakonis, MD, PHD, The Eye Institute of West Florida, Largo, FL

Date: The poster presentation will be available on the AAO meeting portal starting November 11, 2020

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

Contacts

Thomas R. Staab, II, CFO

ir.contact@lensar.com

Lee Roth / Cameron Radinovic

Burns McClellan for LENSAR

lroth@burnsmc.com / cradinovic@burnsmc.com

Staff

Recent Posts

Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement

Proposed business combination to create a North American technology company with an AI-driven fintech marketplace.…

3 hours ago

Dr. Ji Han’s NY Spine Care Offers Cutting-Edge Interventional Pain Management

NEW YORK, NY / ACCESSWIRE / March 25, 2024 / Chronic pain affects millions of…

6 hours ago

FendX Technologies Announces Second Closing of Non-Brokered Private Placement and Announces Further Upsizing to $2 million

Oakville, Ontario--(Newsfile Corp. - March 25, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

9 hours ago

VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update

Conference call to discuss financial and operational results scheduled for Tuesday, March 26 at 8:30…

9 hours ago

Brüush Receives Additional Delisting Notification to Address at Hearing

VANCOUVER, BC / ACCESSWIRE / March 25, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the…

9 hours ago